Related Experiment Video
Updated: Jul 11, 2025

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
Modeling Path Importance for Effective Alzheimer's Disease Drug Repurposing
Shunian Xiang1, Patrick J Lawrence1, Bo Peng2
1Biomedical Informatics Department, The Ohio State University, Columbus, OH 43210, USA.
This study introduces MPI, a novel network-based method for Alzheimer's disease (AD) drug repurposing. MPI prioritizes important network paths, improving the identification of potential AD drugs compared to traditional shortest path methods.
Area of Science:
- Computational biology
- Pharmacology
- Neuroscience
Background:
- Drug repurposing is an efficient strategy for Alzheimer's disease (AD) drug discovery.
- Network-based methods leverage interaction data for identifying candidate drugs.
- Existing methods often overlook the varying importance of network paths of the same length.
Conclusions:
- MPI offers a more effective approach to AD drug repurposing by differentiating path importance.
- Learned node embeddings are crucial for capturing network structure and prioritizing therapeutic paths.
- Further investigation of etodolac, nicotine, and BBB-crossing ACE-INHs is warranted for potential AD repurposing strategies.
More Related Videos
10:02Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Drug Discovery: Overview